Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Physiotherapy Equipment Market Size to Hit USD 38.2 Billion by 2032, at a CAGR of 6.9% - SNS Insider
Austin, United States, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Physiotherapy Equipment Market Size & Growth Analysis According to SNS Insider report published in February 2025, the global...
-
Austin, United States, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Opioid Use Disorder Market Size & Growth Analysis: According to SNS Insider, The Opioid Use Disorder Market size was valued at USD 3.7...
-
MIAMI, FL, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high...
-
Relmada purchases Sepranolone, a Phase 2b ready asset, for the treatment of Tourette syndrome (TS) and other compulsion-related conditions from Asarina Pharma AB Phase 2a results signaled...
-
US & Canada, Feb. 06, 2025 (GLOBE NEWSWIRE) -- US & Canada, Jan. 31, 2025 (GLOBE NEWSWIRE) -- According to a comprehensive report from The Insight Partners, “Pediatric Mask Market Size and...
-
Perrysburg, Ohio, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Revive Health, a leading telehealth provider headquartered in Perrysburg, Ohio, is proud to announce its rebranding to Rixa Health, a name that...
-
Teaming up to raise awareness of the continuing toll of COVID-19 in America, an ongoing mass disabling event causing an American death approximately every 9 minutes with over 59,000 deaths and 665,000...
-
SEATTLE, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the prevention and treatment...
-
-- Advancement to Stage 2 of Infant Study Supported by Review of Stage 1 Safety and Tolerability Data -- -- Company Expects to Announce VAX-31 Infant Study Topline Safety, Tolerability and...
-
Saint Herblain (France), le 5 février 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd’hui que l’autorité de santé britannique Medicines...